Trademark applications and grants for Lorus Therapeutics Inc. Lorus Therapeutics Inc has 5 trademark applications. The latest application filed is for "LORUS"
Patent Application | Date |
---|---|
USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER 20110158936 - 11/817914 Wright; Jim A. ;   et al. | 2011-06-30 |
2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS 20110152337 - 12/976122 AL-QAWASMEH; RAED H. ;   et al. | 2011-06-23 |
SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AND USES THEREOF 20100204305 - 12/700563 YOUNG; Aiping H. ;   et al. | 2010-08-12 |
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer 20100197766 - 12/691664 WRIGHT; Jim A. ;   et al. | 2010-08-05 |
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer 20090118205 - 10/545152 WRIGHT; Jim ;   et al. | 2009-05-07 |
NCAGE Code | L6432 | LORUS THERAPEUTICS INC |
CAGE Code | L6432 | LORUS THERAPEUTICS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.